Home・Aandelen Lijst・DaVita Inc

DaVita Inc

Open

SectorGezondheidszorg

228.06 -2.35

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

221.87

Max

241.65

Belangrijke statistieken
By Trading Economics
Inkomsten	-804M 275M
Verkoop	-204M 3.4B
K/W Sectorgemiddelde	22.679 64.641
EPS	2.87
Winstmarge	8.052
Werknemers	78,000
EBITDA	-62M 655M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	-0.8% downside

Dividenden
By Acuity
Volgende Winsten	4 aug 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	5B 15B
Vorige openingsprijs	230.41
Vorige sluitingsprijs	228.06

Nieuwssentiment

By Acuity

66%

34%

290 / 340 Rangschikking in Healthcare

DaVita Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

3 aug 2026, 20:02 UTC

DaVita Inc shares are lower today amid a decline in the Health Care Services sub-sector, despite earlier gains and unusually high trading volume.

31 jul 2026, 19:36 UTC

DaVita Inc shares are higher today, maintaining a positive trend since Thursday's close. The stock remains near the upper end of its one-month trading range.

29 jul 2026, 19:15 UTC

DaVita Inc shares are higher today, despite pulling back from an earlier peak. Market sentiment is shaped by expectations for the Federal Reserve's policy announcement.

28 jul 2026, 17:51 UTC

News

DaVita Inc. shares are higher following the release of its 2025 Community Care Report, which details initiatives to enhance healthcare access for diverse populations.

27 jul 2026, 22:11 UTC

Shares of DaVita Inc. are higher in after-market hours, maintaining a trend above the 20-day moving average after three consecutive sessions of gains.

24 jul 2026, 18:21 UTC

News

DaVita Inc. shares are higher as market capitalization reaches $14.90 billion, following its rise to #492 in the S&P 500.

22 jul 2026, 20:01 UTC

DaVita Inc. shares are lower amid broader weakness in the Health Care Services sub-sector. The stock reached a low during Wednesday's trading session.

20 jul 2026, 18:26 UTC

DaVita Inc's shares are lower amid broader market dynamics. The US 10Y Treasury Bond index has declined, reflecting rising yields and inflation concerns.

Peer Vergelijking

Prijswijziging

DaVita Inc Prognose

Koersdoel

By TipRanks

-0.8% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 231.8 USD -0.8%

Hoogste 270 USD

Laagste 201 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor DaVita Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

5 ratings

Buy

Hold

Sell

Gebaseerd op 5 analisten die aandelenratings hebben gegeven aan DaVita Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

290 / 340 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over DaVita Inc

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.